231 related articles for article (PubMed ID: 7688076)
41. Somatosensory amplification and its relationship to somatosensory, auditory, and visual evoked and event-related potentials (P300).
Nakao M; Barsky AJ; Nishikitani M; Yano E; Murata K
Neurosci Lett; 2007 Mar; 415(2):185-9. PubMed ID: 17267120
[TBL] [Abstract][Full Text] [Related]
42. Assessment of visual and auditory evoked potentials in multiple sclerosis patients with and without fatigue.
Pokryszko-Dragan A; Bilinska M; Gruszka E; Kusinska E; Podemski R
Neurol Sci; 2015 Feb; 36(2):235-42. PubMed ID: 25240278
[TBL] [Abstract][Full Text] [Related]
43. Evoked potentials and electroencephalography in adolescents with phenylketonuria.
Korinthenberg R; Ullrich K; Füllenkemper F
Neuropediatrics; 1988 Nov; 19(4):175-8. PubMed ID: 3264602
[TBL] [Abstract][Full Text] [Related]
44. [Decreased brain function in patients with non-insulin-dependent diabetes mellitus].
Ryu N; Chin K
No To Shinkei; 1995 Jun; 47(6):543-8. PubMed ID: 7605681
[TBL] [Abstract][Full Text] [Related]
45. [Levels of homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid in patients with focal cerebral ischemia].
Chavko M; Kehr J; Vasková M; Eiben E
Cesk Neurol Neurochir; 1989 Oct; 52(6):403-8. PubMed ID: 2483951
[TBL] [Abstract][Full Text] [Related]
46. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
Petrakis IL; Trevisan L; D'Souza C; Gil R; Krasnicki S; Webb E; Heninger G; Cooney N; Krystal JH
Alcohol Clin Exp Res; 1999 Aug; 23(8):1336-41. PubMed ID: 10470976
[TBL] [Abstract][Full Text] [Related]
47. Depression and somatosensory evoked potentials: I. Correlations between SEP and monoamine and purine metabolites in CSF.
Agren H; Osterberg B; Niklasson F; Franzén O
Biol Psychiatry; 1983 Jun; 18(6):635-49. PubMed ID: 6191784
[TBL] [Abstract][Full Text] [Related]
48. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
[TBL] [Abstract][Full Text] [Related]
49. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
[TBL] [Abstract][Full Text] [Related]
50. [Relation of optic myelitis (OM) and multiple sclerosis (MS)].
Tang XF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Feb; 22(1):23-5, 62. PubMed ID: 2805973
[TBL] [Abstract][Full Text] [Related]
51. [Visual and auditory evoked potentials parameters in multiple sclerosis in children].
Steczkowska M; Kaciński M; Kroczka S
Przegl Lek; 2010; 67(9):706-9. PubMed ID: 21387809
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic evaluation of patients with severe head injury by motor evoked potentials induced by transcranial magnetic stimulation--combined analysis with brainstem auditory evoked potentials].
Kaneko M
No To Shinkei; 1995 May; 47(5):491-6. PubMed ID: 7786626
[TBL] [Abstract][Full Text] [Related]
53. Juvenile parkinsonism: a patient with possible primary striatal dysfunction.
Naidu S; Wolfson LI; Sharpless NS
Ann Neurol; 1978 May; 3(5):453-5. PubMed ID: 727726
[TBL] [Abstract][Full Text] [Related]
54. Prolonged brainstem auditory evoked potential latencies in tropical pancreatic diabetics with normal hearing.
Alexander M; Thomas SV; Mohan PK; Narendranathan M
Electromyogr Clin Neurophysiol; 1995 Mar; 35(2):95-8. PubMed ID: 7781579
[TBL] [Abstract][Full Text] [Related]
55. [The concentration of homovanillic acid and leucine-enkephalin in the lumbar CSF of patients with Parkinson's disease before and after madopar treatment].
Liu DK
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):95-8, 126-7. PubMed ID: 2791764
[TBL] [Abstract][Full Text] [Related]
56. Cerebrospinal fluid homovanillic acid and parkinsonism in Huntington's disease.
Kurlan R; Goldblatt D; Zaczek R; Jeffries K; Irvine C; Coyle J; Shoulson I
Ann Neurol; 1988 Aug; 24(2):282-4. PubMed ID: 2972251
[TBL] [Abstract][Full Text] [Related]
57. [Forensic application of brainstem auditory evoked potential in patients with brain concussion].
Zheng XB; Li SY; Huang SX; Ma KX
Fa Yi Xue Za Zhi; 2008 Dec; 24(6):433-4, 441. PubMed ID: 19241970
[TBL] [Abstract][Full Text] [Related]
58. Multimodality evoked potentials: clinical applications and assessment of utility.
Cohen SN; Potvin A; Syndulko K; Pettler-Jennings P; Potvin JH; Tourtellotte WW
Bull Los Angeles Neurol Soc; 1982; 47():55-61. PubMed ID: 7183366
[TBL] [Abstract][Full Text] [Related]
59. [Drug-induced dyskinesia during the treatment of Parkinson disease--biochemical studies].
Friedman A
Neurol Neurochir Pol; 1985; 19(5):401-3. PubMed ID: 2421191
[TBL] [Abstract][Full Text] [Related]
60. Evoked Potentials in Patients With Wilson Disease.
Mihaylova VM; Kosseva OR; Kotzev IA; Georgiev G; Kremensky IM; Todorov TN; Tournev IL
J Clin Neurophysiol; 2022 Sep; 39(6):510-512. PubMed ID: 33181595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
